MILabs completes installation of latest VECTor5CT system at University of Copenhagen

Feb 6 2018

University of Copenhagen installs latest MILabs VECTor⁵CT system to further accelerate neuroscience research.

MILabs announced today that it has successfully completed the installation of its top-of-the-line multimodality PET-SPECT-UHR CT in the laboratory of Prof. Maiken Nedergaard, M.D, D.M.Sci.  – Center for Translational Neuroscience, Division of Glial Disease and Therapeutics.

Prof. Nedergaard is one of the most renowned names in neuroscience who discovered the glymphatic system - the brain equivalent of the lymphatic system – while working at the University of Rochester Medical Center. She is now a professor at University of Copenhagen's Center of Basic and Translational Neuroscience.

The installed MILabs PET/SPECT/CT system is the latest VECTor/CT multimodality system featuring industry-leading molecular, functional and anatomical tomographic imaging capabilities including 0.6 mm PET, 0.14 mm ex-vivo Exirad-SPECT and 0.25 mm in-vivo SPECT, and 3D/4D CT imaging with 4 µm voxel-resolutions.

The Center for Translational Medicine is a world-class institute in brain research, specialized in cerebrospinal fluid (CSF) fluid dynamics and protein clearance, and its dysregulation effect on neurodegenerative disorders, including Alzheimer’s disease.

Dr. Maiken Nedergaard,, whose division focuses on astrocytic physiology and pathology, stated:

This new instrument will facilitate our research of cerebral blood flow and its glial regulation, so that disorders long thought neuronal in nature can now be investigated as disorders principally of glial cells, including both astrocytes and oligodendrocytes as well as their progenitors

Prof. Frederik Beekman, Ph.D., CEO of MILabs B.V., added:

We are extremely pleased to provide enabling ultra-high resolution Exirad-3D and VECTor/CT molecular and functional research tools allowing the Glial Disease and Therapeutics lab for further explore the development of new CNS diagnostic and therapeutic methods based on glial biology